CRI Fellow Dr.
Beiyun C. Liu of St. Jude Children's Research Hospital is exploring whether
converting an immune-silencing form of cell death to an immune-stimulating form
can unleash immune responses against solid tumors. Watch our latest
Immunotherapy Minute video to learn more.
Wednesday, April 7, 2021
Engineering Cancer Cell Death
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment